ArticlePloS one2018

Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.

Nadia Galizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.